Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trial to Reduce Antimicrobial Use In Nursing Home Residents With Alzheimer's Disease and Other Dementias 2.0 (TRAIN-AD 2.0)

NCT05950607 is registered in ClinicalTrials.gov with Hebrew SeniorLife as lead sponsor.

NCT NCT05950607
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05950607 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trial to Reduce Antimicrobial Use In Nursing Home Residents With Alzheimer's Disease and Other Dementias 2.0 (TRAIN-AD 2.0)
Lead sponsor
Hebrew SeniorLife
Phase
Not applicable
Overall status
Recruiting
Start date
November 13, 2023
Completion date
June 30, 2026
Enrollment
750 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, dementia, infections